腎移植患者におけるSARS-CoV-2 mRNAワクチン接種後の抗体反応についての研究（第1報）
Saved in:
| Published in | 移植 Vol. 57; no. 2; pp. 141 - 151 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
一般社団法人 日本移植学会
2022
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0578-7947 2188-0034 |
| DOI | 10.11386/jst.57.2_141 |
Cover
| Author | 尾本, 和也 飯塚, 淳平 神澤, 太一 石井, 晃大 海上, 耕平 八木澤, 隆史 田邉, 一成 古澤, 美由紀 石田, 英樹 高木, 敏男 |
|---|---|
| Author_xml | – sequence: 1 fullname: 尾本, 和也 organization: 東京女子医科大学泌尿器科 – sequence: 1 fullname: 田邉, 一成 organization: 東京女子医科大学泌尿器科 – sequence: 1 fullname: 高木, 敏男 organization: 東京女子医科大学泌尿器科 – sequence: 1 fullname: 飯塚, 淳平 organization: 東京女子医科大学泌尿器科 – sequence: 1 fullname: 石井, 晃大 organization: 東京女子医科大学泌尿器科 – sequence: 1 fullname: 古澤, 美由紀 organization: 東京女子医科大学泌尿器科 – sequence: 1 fullname: 石田, 英樹 organization: 東京女子医科大学移植管理科 – sequence: 1 fullname: 神澤, 太一 organization: 東京女子医科大学泌尿器科 – sequence: 1 fullname: 海上, 耕平 organization: 東京女子医科大学移植管理科 – sequence: 1 fullname: 八木澤, 隆史 organization: 東京女子医科大学泌尿器科 |
| BookMark | eNo9kEtLAlEAhS9hkJnL9v2BsXtn7sy9d9FCpBdIgVbbYZ6lqMmMm3aNJpSlEQVtWgjZi0SJoE1WP-Y2jjv_QtODNufA-ThncaZBpLRbsgCYRTCBkESV-bxbScgkIaoIowkQFRGlAoQSjoAolAkVCMNkCsRdN6dDKNKQQykKyqN6K7h7HXaaw-r1aL_OvUfuNbh3xqvH2WQmK6R2twRxrphZS_Jan1f7vObx2vOwdRPc9_z3E-71ho3Lz7dz_7Tpf1z91DvcO-DebYiC9kXw8DIeHAbdLvLbT-PB0QyYtLWCa8X_PAY2lxY3UitCen15NZVMC3lEiCYY2BRNnRFFNzC1JQtShLBCEYSUYcPUmKkrIrOpYkBqmaKMkS1bDCqYIaboTJdiYOF3N_xF27bUspMras6eqjmVnFGw1DBWZaKK3xI-9p8bO5qj5jXpCxWqh2k |
| ContentType | Journal Article |
| Copyright | 2022 一般社団法人 日本移植学会 |
| Copyright_xml | – notice: 2022 一般社団法人 日本移植学会 |
| DOI | 10.11386/jst.57.2_141 |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2188-0034 |
| EndPage | 151 |
| ExternalDocumentID | article_jst_57_2_57_141_article_char_ja |
| GroupedDBID | 5GY ALMA_UNASSIGNED_HOLDINGS JSF KQ8 MOJWN OK1 RJT |
| ID | FETCH-LOGICAL-j177a-c4d2db976bc48f3e0811468100894cda9db629f86c08ed2541f5e90649196b9b3 |
| ISSN | 0578-7947 |
| IngestDate | Wed Sep 03 06:30:53 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | Japanese |
| License | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j177a-c4d2db976bc48f3e0811468100894cda9db629f86c08ed2541f5e90649196b9b3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jst/57/2/57_141/_article/-char/ja |
| PageCount | 11 |
| ParticipantIDs | jstage_primary_article_jst_57_2_57_141_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2022 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – year: 2022 text: 2022 |
| PublicationDecade | 2020 |
| PublicationTitle | 移植 |
| PublicationTitleAlternate | 移植 |
| PublicationYear | 2022 |
| Publisher | 一般社団法人 日本移植学会 |
| Publisher_xml | – name: 一般社団法人 日本移植学会 |
| References | 20) Furer V, Eviatar T, Zisman D, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis 2021; 80 (10) : 1330-1338. 10) Glenn DA, Hegde A, Kotzen E, et al. Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease. Kidney Int Rep 2021; 6: 1407-1410. 3) Jin X, Lian JS, Hu JH. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020; 69 (6) : 1002-1009. 14) Bray RA, Lee J-H, Brescia P, et al. Development and validation of a multiplex, bead-based assay to detect antibodies directed against SARS-CoV-2 proteins. Transplantation 2021; 105 (1) : 79-89. 1) ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTAERA-EDTA Council. Nephrol Dial Transplant 2021; 36 (1) : 87-94. 4) Tian Y, Rong L, Nian W, et al. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51 (9) : 843-851. 22) Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med 2021; 385 (7) : 661-662. 11) Kageyama T, Ikeda K, Tanaka S, et al. Antibody responses to BNT162b2 mRNA COVID-19 vaccine in 2,015 healthcare workers in a single tertiary referral hospital in Japan. medRxiv 2021. 5) Oxley TJ, Mocco J, Majidi S. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020; 382 (20) : 1002-1009. 12) Rincon-Arevalo H, Choi M, Stefanski A-L, et al. Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Sci Immunol 2021; 6 (60) : 1-13. 13) Ng KW, Faulkner N, Cornish GH, et al. Preexisting and de novohumoral immunity to SARS-CoV-2 in humans. Science 2020; 370 (6522) : 1339-1343. 16) Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367: 1260-1263. 25) Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant 2021; 21 (8) : 2719-2726. 17) Walls AC, Park Y-J, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 Spike glycoprotein. Cell 2020; 181: 281-292. 6) Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun 2020; 88: 945-946. 7) Bikdeli B, Madhavan MV, Jimenez D. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 2020; 75 (23) : 2950-2973. 27) Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med 2021; 27 (7) : 1205-1211. 2) Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020; 5 (5) : 428-430. 18) Graham C, Seow J, Huettner I, et al. Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. Immunity 2021; 54 (6) : 1276-1289. 23) Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA 2021; 325: 2204-2206. 9) Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med 2021; 385 (7) : 661-662. 19) Weisberg SP, Connors T, Zhu Y, et al. Distinct antibody responses to SArSA-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol 2021; 22 (1) : 25-31. 24) Benotmane I, Gautier-Vargas G, Cognard N, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int 2021; 99: 1498-1500. 15) Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181: 271-280. 26) Okba NMA, Raj VS, Widjaja I, et al. Sensitive and specific detection of low-level antibody responses in mild Middle East respiratory syndrome coronavirus infections. Emerg Infect Dis 2019; 25: 1868-1877. 8) Azzi Y, Bartash R, Scalea J, et al. COVID-19 and solid organ transplantation: a review article. Transplantation 2021; 105 (1) : 37-55. 21) Eisenberg RA, Jawad AF, Boyer J, et al. Rituximab-treated patients have a poor response to influenza vaccination. J Clin Immunol 2013; 33: 388-396. |
| References_xml | – reference: 5) Oxley TJ, Mocco J, Majidi S. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020; 382 (20) : 1002-1009. – reference: 20) Furer V, Eviatar T, Zisman D, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis 2021; 80 (10) : 1330-1338. – reference: 4) Tian Y, Rong L, Nian W, et al. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51 (9) : 843-851. – reference: 1) ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTAERA-EDTA Council. Nephrol Dial Transplant 2021; 36 (1) : 87-94. – reference: 21) Eisenberg RA, Jawad AF, Boyer J, et al. Rituximab-treated patients have a poor response to influenza vaccination. J Clin Immunol 2013; 33: 388-396. – reference: 12) Rincon-Arevalo H, Choi M, Stefanski A-L, et al. Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Sci Immunol 2021; 6 (60) : 1-13. – reference: 2) Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020; 5 (5) : 428-430. – reference: 6) Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun 2020; 88: 945-946. – reference: 19) Weisberg SP, Connors T, Zhu Y, et al. Distinct antibody responses to SArSA-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol 2021; 22 (1) : 25-31. – reference: 3) Jin X, Lian JS, Hu JH. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020; 69 (6) : 1002-1009. – reference: 16) Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367: 1260-1263. – reference: 23) Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA 2021; 325: 2204-2206. – reference: 7) Bikdeli B, Madhavan MV, Jimenez D. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 2020; 75 (23) : 2950-2973. – reference: 15) Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181: 271-280. – reference: 17) Walls AC, Park Y-J, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 Spike glycoprotein. Cell 2020; 181: 281-292. – reference: 26) Okba NMA, Raj VS, Widjaja I, et al. Sensitive and specific detection of low-level antibody responses in mild Middle East respiratory syndrome coronavirus infections. Emerg Infect Dis 2019; 25: 1868-1877. – reference: 11) Kageyama T, Ikeda K, Tanaka S, et al. Antibody responses to BNT162b2 mRNA COVID-19 vaccine in 2,015 healthcare workers in a single tertiary referral hospital in Japan. medRxiv 2021. – reference: 10) Glenn DA, Hegde A, Kotzen E, et al. Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease. Kidney Int Rep 2021; 6: 1407-1410. – reference: 25) Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant 2021; 21 (8) : 2719-2726. – reference: 14) Bray RA, Lee J-H, Brescia P, et al. Development and validation of a multiplex, bead-based assay to detect antibodies directed against SARS-CoV-2 proteins. Transplantation 2021; 105 (1) : 79-89. – reference: 13) Ng KW, Faulkner N, Cornish GH, et al. Preexisting and de novohumoral immunity to SARS-CoV-2 in humans. Science 2020; 370 (6522) : 1339-1343. – reference: 18) Graham C, Seow J, Huettner I, et al. Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. Immunity 2021; 54 (6) : 1276-1289. – reference: 27) Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med 2021; 27 (7) : 1205-1211. – reference: 8) Azzi Y, Bartash R, Scalea J, et al. COVID-19 and solid organ transplantation: a review article. Transplantation 2021; 105 (1) : 37-55. – reference: 22) Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med 2021; 385 (7) : 661-662. – reference: 9) Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med 2021; 385 (7) : 661-662. – reference: 24) Benotmane I, Gautier-Vargas G, Cognard N, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int 2021; 99: 1498-1500. |
| SSID | ssib002821803 ssib058493041 ssib000872161 ssib005879657 ssj0001032185 |
| Score | 2.2624006 |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 141 |
| SubjectTerms | antibody titer COVID-19 renal transplantation SARS-CoV-2 vaccination |
| Title | 腎移植患者におけるSARS-CoV-2 mRNAワクチン接種後の抗体反応についての研究（第1報） |
| URI | https://www.jstage.jst.go.jp/article/jst/57/2/57_141/_article/-char/ja |
| Volume | 57 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 移植, 2022, Vol.57(2), pp.141-151 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFA-lXryIouI3e3BOkprvmTlOtlmKYsF-SG8hySaHBdui24sn01rQaiui4MVDwfqFpUUEL1b9Y-Lu9tZ_wfcmSTf9ONTCEl5mfjPz3ryZzHvJzFtFua6FLNK1JlPBdNVUS28GamDEjupYAdjreHJABjC9M-qMTFq3puypgcFaZdfSXDscih4deq7kOFqFNNArnpL9D83uVgoJQIN-4QoahuuRdEw8RphNmEc8SgQlrks8hwgwD4eRYAYRpsRoCPNMMBuJcAuCiYLguiQMwtxxMTau1mfuqcaN-2OjOcAkolEACkKWygnXlA15RNiSB0YEMGMT1yOsXrboSYwgnBLPIu4w4SZiWEPyCeAG4fX97IEUBZ8lIZxKhdCWRrglCU5cyGoQt04Ykyl1-OlYNYBcvczjVUv8YJeVY0-ypKEIkMOxKhyHmMoNKRXIwAlv9PEUOYEiHpfdyHM8JMmuR-EZ4Vofz1FMzsr6WY6HG9kpRXV0Dz7XAggE-hIl3qVSATby45rVFzhG39GvMMKQERAHRbekgCCTKweJgzVB-wgW8Mv5oVKvZS8cMsiAoWGpGAt7mIvKugIPaRUew7kYsUwDQ4-pGKuoujDmkcOLB4BRWeX0PFZZYTDpecTgg2uxKb8Nth62h2w6ZPi7pfaENy8mjw8w36a-gRdA-mU6Hj70W-ABnTAo1XHT7u27VQcCg0_tOYmts8q-AptRXvmuD9Y2N7XCAZBvYTUTCsh9zmWvlIF4gfubVd7BRIXb3c2e0v6cOK2cKhzHmsgZPqMMtIKzyuz24krv08_u2nJ3_v3248Us_ZqlS1n6Kpt_3p_LNZzL2cJmNr-ZLaTZwvfuyofe543O7xdZutFdevv31-vOy-XOn3ey-FqWPsnSj5DVW33T-_JjZ-tpb31d76x-29l6dk6ZbHgT9RG1-A8VtaVTGqiR1TSaIfgcYWSxxIzBA8DDlhjSi1tRM-DN0DF4wpxIY3HTsC09sWMOfgqHpTnkoXleGZyemY4vKDVNT2LbTqLEZonFNTOMIi0OgjCwEholCb2oOHkH-bN5oBz_iLq9dNyCl5WTOKHyN6JXlMH2g7n4KvgI7fCaHCb_AEwI4dk |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%85%8E%E7%A7%BB%E6%A4%8D%E6%82%A3%E8%80%85%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8BSARS-CoV-2+mRNA%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3%E6%8E%A5%E7%A8%AE%E5%BE%8C%E3%81%AE%E6%8A%97%E4%BD%93%E5%8F%8D%E5%BF%9C%E3%81%AB%E3%81%A4%E3%81%84%E3%81%A6%E3%81%AE%E7%A0%94%E7%A9%B6%EF%BC%88%E7%AC%AC1%E5%A0%B1%EF%BC%89&rft.jtitle=%E7%A7%BB%E6%A4%8D&rft.au=%E5%B0%BE%E6%9C%AC%2C+%E5%92%8C%E4%B9%9F&rft.au=%E7%94%B0%E9%82%89%2C+%E4%B8%80%E6%88%90&rft.au=%E9%AB%98%E6%9C%A8%2C+%E6%95%8F%E7%94%B7&rft.au=%E9%A3%AF%E5%A1%9A%2C+%E6%B7%B3%E5%B9%B3&rft.date=2022&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E7%A7%BB%E6%A4%8D%E5%AD%A6%E4%BC%9A&rft.issn=0578-7947&rft.eissn=2188-0034&rft.volume=57&rft.issue=2&rft.spage=141&rft.epage=151&rft_id=info:doi/10.11386%2Fjst.57.2_141&rft.externalDocID=article_jst_57_2_57_141_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0578-7947&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0578-7947&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0578-7947&client=summon |